Key statistics
As of last trade United Therapeutics Corp (U2TH34:SAO) traded at 128.24, -11.00% below its 52-week high of 144.09, set on Dec 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 128.24 |
|---|---|
| High | 128.24 |
| Low | 128.24 |
| Bid | 132.73 |
| Offer | 138.32 |
| Previous close | 128.24 |
| Average volume | 1.00 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 02 2026 13:42 GMT.
More ▼
Press releases
- United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
- United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
- United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
- United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
- United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
- United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
